Long-term efficacy of pembrolizumab (pembro; MK-3475) in a pooled analysis of 655 patients (pts) with advanced melanoma (MEL) enrolled in KEYNOTE-001 Meeting Abstract
| Authors: | Daud, A.; Ribas, A.; Robert, C.; Hodi, F. S.; Wolchok, J. D.; Joshua, A. M.; Hwu, W. J.; Weber, J. S.; Gangadhar, T. C.; Joseph, R. W.; Dronca, R. S.; Patnaik, A.; Zarour, H. M.; Kefford, R.; Lindia, J. A.; Li, X. N.; Ebbinghaus, S.; Kang, S. P.; Hamid, O. |
| Abstract Title: | Long-term efficacy of pembrolizumab (pembro; MK-3475) in a pooled analysis of 655 patients (pts) with advanced melanoma (MEL) enrolled in KEYNOTE-001 |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901915 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.9005 |
| Notes: | Meeting Abstract: 9005 -- Source: Wos |
